The association between FTO gene polymorphism rs9939609 and obesity is sex-specific in the population of PURE study in Poland.


Journal

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
ISSN: 1899-5276
Titre abrégé: Adv Clin Exp Med
Pays: Poland
ID NLM: 101138582

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 23 1 2020
medline: 3 3 2020
entrez: 23 1 2020
Statut: ppublish

Résumé

Fat mass and obesity-associated gene (FTO) polymorphism remains the strongest known genetic determinant of common obesity. However, its influence depends on ethnicity, and the FTO-mediated predisposition to other metabolic disturbances is questionable. The aim of our study was to evaluate the association between FTO rs9939609 polymorphism and metabolic syndrome in a population of Prospective Urban Rural Epidemiology (PURE) study in Poland. We enrolled 1,097 participants of the PURE study (683 women and 414 men) from the Lower Silesian voivodeship. Anthropometrical parameters and blood pressure were measured. Blood samples were taken for an examination of lipid profile and fasting glucose level. Genomic DNA was isolated and FTO polymorphism rs9939609 was genotyped. Male A-allele carriers had significantly higher mean body mass, body mass index (BMI), waist-to-hip ratio (WHR), and waist and hip circumferences than men without risk allele. They were also more often diagnosed with obesity on the basis of BMI and central obesity parameters. No such influence was observed in women. There were no significant associations between FTO polymorphism and metabolic syndrome or its components. Our results suggest a sex-specific association between FTO polymorphism and obesity traits. The occurrence of metabolic syndrome or its components was not related with FTO gene variation in our cohort.

Sections du résumé

BACKGROUND BACKGROUND
Fat mass and obesity-associated gene (FTO) polymorphism remains the strongest known genetic determinant of common obesity. However, its influence depends on ethnicity, and the FTO-mediated predisposition to other metabolic disturbances is questionable.
OBJECTIVES OBJECTIVE
The aim of our study was to evaluate the association between FTO rs9939609 polymorphism and metabolic syndrome in a population of Prospective Urban Rural Epidemiology (PURE) study in Poland.
MATERIAL AND METHODS METHODS
We enrolled 1,097 participants of the PURE study (683 women and 414 men) from the Lower Silesian voivodeship. Anthropometrical parameters and blood pressure were measured. Blood samples were taken for an examination of lipid profile and fasting glucose level. Genomic DNA was isolated and FTO polymorphism rs9939609 was genotyped.
RESULTS RESULTS
Male A-allele carriers had significantly higher mean body mass, body mass index (BMI), waist-to-hip ratio (WHR), and waist and hip circumferences than men without risk allele. They were also more often diagnosed with obesity on the basis of BMI and central obesity parameters. No such influence was observed in women. There were no significant associations between FTO polymorphism and metabolic syndrome or its components.
CONCLUSIONS CONCLUSIONS
Our results suggest a sex-specific association between FTO polymorphism and obesity traits. The occurrence of metabolic syndrome or its components was not related with FTO gene variation in our cohort.

Identifiants

pubmed: 31967745
doi: 10.17219/acem/111811
doi:

Substances chimiques

Proteins 0
Alpha-Ketoglutarate-Dependent Dioxygenase FTO EC 1.14.11.33
FTO protein, human EC 1.14.11.33

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-32

Auteurs

Aleksandra Zdrojowy-Wełna (A)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Poland.

Grażyna Bednarek-Tupikowska (G)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Poland.

Katarzyna Zatońska (K)

Department of Social Medicine, Wroclaw Medical University, Poland.

Katarzyna Kolačkov (K)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Poland.

Alicja Jokiel-Rokita (A)

Department of Pure and Applied Mathematics, Wroclaw University of Science and Technology, Poland.

Marek Bolanowski (M)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH